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Tuberculosis compulsory treatment:  
advancement or retrogression? 
 
Considering that tuberculosis (Tb) still kills approximately 3 million people per year in the world and it is the third 
infectious disease in the number of people killed, several reflections are valid to improve the drop-outs, which are 
the main problem of the programs of tuberculosis control, since the treatment schedules currently available are 
highly efficient. 
Since 1993, tuberculosis control was pointed out as a worldwide emergency situation by the World Health 
Organization (WHO). Goals were established to cure 85% of the new cases, to diagnose 70% of the new patients 
in 2005 and to reduce the mortality in 50% in 2010. 
In 1963, Fox (1), admitted that the regularity and efficacy of the schedule used were of major importance, and 
Addington (2), in 1979 considered treatment drop-out as the most severe problem in tuberculosis control. 
WHO recommends the administration of medicines by means of directly observed therapy (DOT), i.e., observing 
the patient swallowing the medication. Later on, according to local conditions, this WHO method was transformed 
into DOTS strategy (directly observed therapy short-course), which should be adapted to each particular local 
condition (3,4). 
Therefore DOTS strategy should fulfill five basic rules: 1) government involvement with Tuberculosis 
Program/trained and interested working team, 2) laboratory net with equipment and qualified human resources 
(BAAR research), 3) to administer and observe the patient swallowing the medication, 4) supply of free medication 
for treatment (including rifampicin), 5) information system to monitor the cases, their treatment, evolution and 
results (3,5,6). 
DOTS experience in NY, from 1992 to 1995, showed a substantial improvement in the local tuberculosis 
control program, reducing the incidence of new cases in 35% and the incidence of multi-resistant tuberculosis cases 
in 75%, with a cost of approximately 40 million dollars to treat 3.000 patients (7,8). DOTS-related and auto-
administrated treatment cost analyses showed the advantage of DOTS, taking into consideration the early reduction 
of transmission, increased number of cured cases, early detection of drop-outs and reduction of cases of multi-
resistant tuberculosis (9,10).  
Dots treatment quickly spread to other states in the U.S. However, even placing almost 90% of tuberculosis 
patients in the DOTS strategy in the USA, approximately 18% do not adhere (11). Simultaneous studies on 
tuberculosis transmission confirmed by means of molecular biology, new Tb cases coming from strain of non-
adherent patients. With the concern of being able to also treat the non-adherent patients with DOTS, New York 
was the first U.S. state to develop quarantine laws (7). 
According to a metanalysis on DOTS, four studies used involuntatory hospitalizations for non-adherent patients 
in 2000 (New York, Baltimore, South Carolina and Tarrant) (12). 
New York City Health Code, of April 1993, states that all patients with Tb or suspected to have Tb must: be 
examined; complete treatment for Tb; adhere to a DOT program (or CoDOT, when administered by a justice 
commissary; be retained throughout the transmission period and be restrained even without active infection, until 
the cure, if necessary, and when other more reasonable treatment alternatives failed (7). Therefore, renitent patients 
were treated under a CoDOTS system or admitted to “closed” hospitals specifically directed towards this purpose, 
they were “released” to DOTS when the adherence to the treatment improved and there were no risk of bacillus 
transmission to the community (13). 
Thus, in the Denver Program of Tuberculosis Control, 5% of the patients were treated in a “closed” hospital plan 
due to their non-adherence, and in 5% of these patients there was a loss of follow-up, and if these patients were 
found, they became candidates to a new compulsory hospitalization (13). In New York and South Carolina, less than 
1% of the patients was compulsorily admitted. In Tarrant, Texas, 6.2% were submitted to compulsory 
hospitalization or put in quarantine due to non-adherence. The existence of regional differences in DOTS and 
confinement criteria must be emphasized, and that in all cases of compulsory hospitalization there was a 
predominance of alcoholic, psychiatric, homeless and drug addict patients (14). 
According to Sbarbaro (1977) (15), Tb is not an individual, but a social disease, that spreads through the air to 
other members of society (without their consent or knowledge); it is preventable and curable, if diagnosed and 
treated correctly and, therefore, treatment success depends on a responsible Health Department. 
Based on these assumptions and in the cost of non-adherence (“pay now or pay much more later”), there are 
current laws that foresee compulsory hospitalization in all 50 American States (16). 
In Brazil, considering the worse social conditions and poverty and lower cure rates and abandonment, several 
strategies to warrant cure and to reduce these patient’s drop-outs must still be used in renitent patients, 
emphasizing that we must initially assure the best program conditions. 
 The National Program of Tuberculosis Control attempts to equip the municipalities to increase the detection of 
new cases, and therefore created the Law 3739, providing financial incentive to the districts for each cure-related 
discharge of patients.  
In the large urban centers, decentralized attendance, trained teams and longer assistance hours, especially for 
patients who work, would warrant the administration of supervised treatment, adapted according to the local 
conditions, stressing the daily supervision in the first two months of treatment, and the supervision twice/week 
from the third to the sixth month. In places with Family Health Program, the supervised treatment could be assured 
by means of health community agents to confirm that the patient swallowed the medication. 
Other measures, such as patients’ education, transportation tickets and basic food supply help to increase 
adherence to the treatment. In fact, any incentive incorporated to the current practice helps to increase the 
adherence (17). 
For renitent patients, judicial measurements may be adopted. Family and Children’s Courts usually respond well 
to this demand, as long as it is proved that children are not receiving the essential medication from their parents or 
that children are at risk of getting tuberculous. Forensic teams, in addition to the lawyer, social workers, 
psychologists, have expert physicians to investigate these cases and renitent patients can even be dealt with by 
means of a judicial compulsory hospitalization. 
It must be emphasized that compulsory hospitalization will occur only after all previously discussed measures have 
been tried. It should also be stresses that beds currently available to tuberculosis in the hospitals have a high rate of 
releases either by request or insubordination, reflecting that much more must be done to improve our strategy. The 
commitment of several health professionals in these hospitals must be valued, including occupational therapy, social 
work, concomitant treatment of alcoholism and drug abuse. The exchange between these hospitals and the basic 
health system is necessary, in order to monitor these patients’ evolution to ambulatory treatment, assuring the 
continuity of the work carried out by the multiprofessional team in the hospitals. 
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